Vitamin Shoppe: Expensive For A Company Facing Headwinds | Seeking Alpha VSI's revenue growth is expected to slow while margins contract. Headwinds include persistently negative press on the questionable benefits of vitamins. Vitamin Shoppe (NYSE: VSI ) is a multi channel specialty retailer and and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products. The company operates through three business segments: Retail, Direct and Manufacturing. The Retail segment includes vitamin shoppe, super supplements and vitapath retail store formats. The Direct segment consists of internet and catalog formats. The Manufacturing segment consists of Nutri-Force manufacturing operations. The company is facing headwinds as the industry suffering from scientific evidence that fish oil supplements and mutli-vitamins do not work. Here is a 2013 article describing the disappointing fish oil studies that hurt industry sales. Fast forward to 2015, and the negative media continues . Competition in the vitamin space is also very fierce, especially from on-line retailers since supplements' high value-to-weight ratio makes it ideal for e-commerce. As a result, VSI's revenue growth is expected to slow significantly. To make matters worse, margins is expected to shrink as well. Given the negative headwinds, it is difficult to justify VSI's PEG ratio of 2.0x vs. 1.4x for the S&P 500. The stock appears fully valued at best. VSI is currently trading at $35.57 per share, a market value of $1,049 million, and an enterprise value of $1,045 million. The stock does not pay a dividend vs. a dividend yield of 2.0% for the S&P 500. The stock performed very poorly over the past year, returning -1,177 basis points relative to the S&P 500, or -10.2% in absolute return. The stock is 13.6% below its 200-day moving average of $41.17 and over the past 52 weeks have traded at a high of $49.04 and a low of $33.6. Short interest is stands at 11.2% of float. VSI's revenue grew by a CAGR of 12.3% over the past 3 full fiscal years. Analysts' consensus is forecasting revenues to grow 5.2% this fiscal year, reaching $1,276 million and by 5.5% the following fiscal year, reaching $1,346 million. Over the past three full fiscal years, VSI's EBIT margin decreased by 43 basis points from 8.9% to 8.5%. Analysts' consensus is forecasting EBIT margin to contract by 58 basis points this fiscal year to 7.9%, and contract by 27 basis points the following fiscal year to 8.2%. Over the past 3 years, management decreased its diluted outstanding common shares by 1.5%. As a result of the revenue, margin, and share dynamics, EPS grew at a CAGR of 9.6% over the past 3 fiscal years. Going forward, consensus is forecasting EPS is to increase by 4.1% reaching $2.08 this fiscal year and to increase by 11.7% reaching $2.33 the following fiscal year. Profitability metrics are strong. ROA is 9.2% ROE is 13.7%, and ROIC is 12.6%. The balance sheet looks solid. The company has a net cash position of $4 million or $0.14 per share. Debt to Equity is 0%, current ratio is 1.8 and Altman's Z Score is 7.9. Using consensus estimates for next fiscal year's results (FY2), VSI is currently trading at an EV/Sales multiple of 0.8, an EV/EBIT multiple of 9.5, a P/E multiple of 15.3, and a FCF multiple of 15.8. Relative to the S&P 500, VSI is trading at EV/Sales discount of 52.5%, an EV/EBIT discount of 27.7%, P/E premium of 1.6%, and FCF discount of 10.8%. VSI's PEG ratio is currently 2.0 compared to the S&P 500's PEG ratio of 1.4 - this is a premium of 42.1%. Focusing in on the key EV/EBIT, P/E, and FCF metrics, VSI deserves a -15.0% premium to the S&P 500 due to its slowing growth rate and compressing margins. Applying such a premium to these valuation metrics implies a price target of $35.15 or a -1.2% downside risk from the current price. Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. We only use your contact details to reply to your request for more information. We do not sell the personal contact data you submit to anyone else. Thank you for your interest in Seeking Alpha PRO We look forward to contacting you shortly for a conversation. Thank you for your interest in Seeking Alpha PRO Our PRO subscription service was created for fund managers, and the cost of the product is prohibitive for most individual investors.  If you are an investment professional with over $1M AUM and received this message in error, click here and you will be contacted shortly. Thank you for your interest in Seeking Alpha PRO We look forward to contacting you when we have an individual investor product ready! 